09:27 AM EDT, 07/30/2025 (MT Newswires) -- KKR (KKR) said Wednesday that it has acquired a majority ownership stake in HealthCare Royalty Partners, a biopharma royalty acquisition company.

Financial terms were not disclosed.

As part of the deal, KKR said HealthCare Royalty Chairman and CEO Clarke Futch will continue to lead the company, and will hold a "substantial" minority stake.

KKR said HealthCare Royalty manages approximately $3 billion in assets with a portfolio of more than 10 therapeutic areas and over 55 products.